We offer our registered users tailored information, free online courses and exclusive content.
Registration is FREE of charge.
For further information please contact:
EXCEMED
Alessia Addessi alessia.addessi@external.excemed.org
AcademicCME
Nicole McMenamin nmcmenamin@academiccme.com
Chelsey Benedek cbenedek@academiccme.com
EXCEMED, in collaboration with the European Charcot Foundation (ECF) and AcademicCME, is planning a Virtual Course to be held prior to the ECTRIMS Congress.
The 2021 Joint Pre-ECTRIMS Live Online Workshop is endorsed by ECTRIMS.
This live, Online Programme will take place at 15.00 (CEST), on both 11th & 12th October, 2021. International experts will address the main scientific breakthroughs in the field and will provide practical suggestions for managing patients in clinical practice.
Understanding and cure of Multiple Sclerosis is rapidly improving through the wide application of new technologies. They are used in all MS fields, like development of biomarkers, sophisticated imaging techniques of central nervous system, new drugs with innovative targets as well as new tools for remote patients monitoring.
The recent COVID-19 pandemic has boosted these processes that were already in place in MS in the past years. Nevertheless, the pandemic has also highlighted the need of new information and deep knowledge about the impact of viruses on immunocompromised hosts, such as MS patients, and of vaccines.
There are still many controversial themes, such as how to manage progressive MS patients, that are currently debated among neurologists and neuroscientists involved in MS field.
This workshop aims to provide updated scientific insights on the world of contemporary MS. International experts will address the main scientific breakthroughs in the field and will provide practical suggestions for managing patients in clinical practice.
This continuing education activity has been approved by the International Council of Nurses (ICN) for the award of International Continuing Nursing Education Credits (ICNECs).
The 2021 Joint Pre-Ectrims Online workshop, online, Switzerland, 11/10/2021-12/10/2021 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 7 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activ....
Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.
15.00-15.10 Welcome & Opening
Session 1: UNDERSTANDING MULTIPLE SCLEROSIS
15.10-15.30 Emerging environmental factors triggering MS: the gut-brain axis
S. Baranzini, US
15.30-15.50 Immunosenescence and MS
A.Bar-Or, Canada
15.50-16.05 Q&A
Session 2: TREATING MULTIPLE SCLEROSIS
16.05-16.25 Present and future of treating relapsing MS
F.D. Lublin, US
16.25-16.45 Present and future of treating progression
G. Comi, Italy
16.45-16.55 Break
16.55-17.15 Enhancing recovery: new approaches
L. Leocani, Italy
17.15-17.35 MS and demyelinating diseases in children
B. Banwell, US
17.35-17.50 Q&A
Session 3: MONITORING MULTIPLE SCLEROSIS
17.50-18.10 Updated Role of MRI in Monitoring MS
F. Barkhof, the Netherlands
18.10-18.30 Diagnosis and monitoring of cognitive functions in MS
I.K. Penner, Germany
18.30-18.45 Q&A
18.45-19.30 Panel Discussion on “Lesson learned from COVID-19”
C. Harris, Canada
A. Perrin Ross, USA
M.A. Robles Sanchez, Spain
19.30 End of Day 1
Session 4: PATIENT REPORTED OUTCOMES: NEW PERSPECTIVES
15.00-15.20 The PROMS initiative
P. Zaratin, Italy
15.20-15.40 Research, validation and development
P. Vermersch, France
15.40-16.00 Role in clinical management
R. McBurney, US
16.00-16.15 Q&A
16.15-16.25 Break
Session 5: MS CONTROVERSIES 2021- THE FUTURE OF MS CARE
16.25-16.45 New evidence on the role of oligodendrocytes and OPCs in MS
C. Lubetzki, France
16.45-17.05 Moving fluid biomarkers into the clinic
M. Comabella, Spain
J. Kuhle, Switzerland
17.05-18.00 Round Table: MS care in this and the next pandemic: transcontinental perspective
J. Correale, Argentina
A. Cross, US
G. Giovannoni, UK
18.00-18.15 Q&A
18.15-18.30 Wrap up and closing remarks
18.30 End of the workshop
